7TM raises $22.2 million

7TM (Horsholm, Denmark) raised DKK123 million ($22.2 million) in a series D round led by SR One. 7TM's neuropeptide Y (NPY) receptor agonists obinepitide ( TM30338) and TM30339 are in Phase I/II testi...